EGFR/HER2-IN-19 (Compound L1) is a dual inhibitor against epidermal growth factor receptor ( EGFR ) and human epidermal growth factor receptor 2 ( HER2 ). EGFR/HER2-IN-19 is promising for research of cancers driven by EGFR/HER2.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > EGFR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。